Literature DB >> 1645787

Negative regulation of the BZLF1 promoter of Epstein-Barr virus.

E A Montalvo1, Y Shi, T E Shenk, A J Levine.   

Abstract

The Epstein-Barr virus BZLF1 gene product (ZEBRA) is a transcriptional activator whose expression in latently infected B cells is sufficient to induce the viral lytic cycle. Since there is no transcription of BZLF1 during latency, we carried out experiments to determine whether cis-acting negative elements in the BZLF1 promoter contribute to the lack of expression during this phase of the virus cycle. A series of deletion plasmids encompassing positions -551 to +14 of the BZLF1 promoter region were constructed and tested for the ability to drive chloramphenicol acetyltransferase (CAT) gene expression in the absence of inducing agents such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and anti-immunoglobulin. Expression from the intact 551-bp region was very weak in most of the cell lines tested, but deletion of 165 bp from the 5' end caused a sevenfold increase in expression of CAT. Within these 165 bp, a minimal 48-bp region was sufficient to down regulate the expression of a simian virus 40/CAT fusion plasmid. The 48-bp negative element consists of 7-bp dyad symmetry elements separated by 27 bp. The rightmost half of the dyad symmetry element partially overlaps a region which has a 14-of-15-bp homology to the human cytoskeletal gamma-actin promoter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645787      PMCID: PMC241374     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; J C Lin; E C Mar; J Pagano
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

2.  Organization of the transcriptional control region of the E1b gene of adenovirus type 5.

Authors:  C L Parks; S Banerjee; D J Spector
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Negative regulation of serum-responsive enhancer elements.

Authors:  M Subramaniam; L J Schmidt; C E Crutchfield; M J Getz
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

4.  A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing.

Authors:  K A Lee; A Bindereif; M R Green
Journal:  Gene Anal Tech       Date:  1988 Mar-Apr

5.  Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes.

Authors:  K Walsh
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

Authors:  J Schütte; J Viallet; M Nau; S Segal; J Fedorko; J Minna
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

7.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

9.  Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Authors:  P J Farrell; D T Rowe; C M Rooney; T Kouzarides
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Two distinct cellular phosphoproteins bind to the c-fos serum response element.

Authors:  W A Ryan; B R Franza; M Z Gilman
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

View more
  37 in total

1.  Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

Authors:  R J Kraus; S J Mirocha; H M Stephany; J R Puchalski; J E Mertz
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Authors:  S Zalani; E A Holley-Guthrie; D E Gutsch; S C Kenney
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Promoter sequences required for reactivation of Epstein-Barr virus from latency.

Authors:  Ulrich K Binné; Wolfgang Amon; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  DNA binding sites for the transcriptional activator/repressor YY1.

Authors:  R P Hyde-DeRuyscher; E Jennings; T Shenk
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

6.  Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus.

Authors:  P J Chang; Y S Chang; S T Liu
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.

Authors:  S Zalani; A Coppage; E Holley-Guthrie; S Kenney
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.

Authors:  Xianming Yu; Patrick J McCarthy; Zhenxun Wang; Daniel A Gorlen; Janet E Mertz
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

9.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.